TY  - GEN 
AU  - Gómez-Llobell, M.
AU  - Peleteiro Raindo, Andrés
AU  - Climent Medina, J.
AU  - Gómez Centurión, I.
AU  - Mosquera Orgueira, Adrián
PY  - 2022
SN  - 2234-943X
UR  - http://hdl.handle.net/20.500.11940/20941
AB  - Background: Experience with immune checkpoint inhibitors (ICIs) in the treatment of acute myeloid leukemia (AML) is still limited and based on early clinical trials, with no reported randomized clinical data. In this study, we reviewed the available...
LA  - eng
TI  - Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis
DO  - 10.3389/fonc.2022.882531
KW  - AS Santiago
KW  - CHUS
KW  - IDIS
VL  - 12
ER  -